世界のOTC医薬品＆栄養補助食品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global OTC Drug and Dietary Supplement Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5920
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、OTC医薬品＆栄養補助食品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、粉末、カプセル、液体）、用途別市場規模（コンビニエンスストア、薬局、スーパー）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・OTC医薬品＆栄養補助食品の市場動向
・企業の競争状況、市場シェア
・OTC医薬品＆栄養補助食品の種類別市場規模と予測2016-2027（錠剤、粉末、カプセル、液体）
・OTC医薬品＆栄養補助食品の用途別市場規模と予測2016-2027（コンビニエンスストア、薬局、スーパー）
・OTC医薬品＆栄養補助食品の北米市場規模2016-2027（アメリカ、カナダ）
・OTC医薬品＆栄養補助食品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・OTC医薬品＆栄養補助食品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・OTC医薬品＆栄養補助食品の中南米市場規模2016-2027（メキシコ、ブラジル）
・OTC医薬品＆栄養補助食品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Amway、Suntory、Glanbia、GSK、Abbott、Herbalife、Reckitt Benckiser、Bayer、Blackmores）
・結論

Dietary supplements include such ingredients as vitamins, minerals, herbs, amino acids, and enzymes. Dietary supplements are marketed in forms such as tablets, capsules, softgels, gelcaps, powders, and liquids.

Market Analysis and Insights: Global OTC Drug and Dietary Supplement Market
The global OTC Drug and Dietary Supplement market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Drug and Dietary Supplement market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Drug and Dietary Supplement market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Drug and Dietary Supplement market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Drug and Dietary Supplement market.

Global OTC Drug and Dietary Supplement Scope and Market Size
OTC Drug and Dietary Supplement market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global OTC Drug and Dietary Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets
Powders
Capsules
Liquids

Segment by Application
Convenience Stores
Pharmacies
Supermarkets

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Amway
Suntory
Glanbia
GSK
Abbott
Herbalife
Reckitt Benckiser
Bayer
Blackmores

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Powders
1.2.4 Capsules
1.2.5 Liquids
1.3 Market by Application
1.3.1 Global OTC Drug and Dietary Supplement Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Convenience Stores
1.3.3 Pharmacies
1.3.4 Supermarkets
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global OTC Drug and Dietary Supplement Market Perspective (2016-2027)
2.2 OTC Drug and Dietary Supplement Growth Trends by Regions
2.2.1 OTC Drug and Dietary Supplement Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 OTC Drug and Dietary Supplement Historic Market Share by Regions (2016-2021)
2.2.3 OTC Drug and Dietary Supplement Forecasted Market Size by Regions (2022-2027)
2.3 OTC Drug and Dietary Supplement Industry Dynamic
2.3.1 OTC Drug and Dietary Supplement Market Trends
2.3.2 OTC Drug and Dietary Supplement Market Drivers
2.3.3 OTC Drug and Dietary Supplement Market Challenges
2.3.4 OTC Drug and Dietary Supplement Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top OTC Drug and Dietary Supplement Players by Revenue
3.1.1 Global Top OTC Drug and Dietary Supplement Players by Revenue (2016-2021)
3.1.2 Global OTC Drug and Dietary Supplement Revenue Market Share by Players (2016-2021)
3.2 Global OTC Drug and Dietary Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by OTC Drug and Dietary Supplement Revenue
3.4 Global OTC Drug and Dietary Supplement Market Concentration Ratio
3.4.1 Global OTC Drug and Dietary Supplement Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Drug and Dietary Supplement Revenue in 2020
3.5 OTC Drug and Dietary Supplement Key Players Head office and Area Served
3.6 Key Players OTC Drug and Dietary Supplement Product Solution and Service
3.7 Date of Enter into OTC Drug and Dietary Supplement Market
3.8 Mergers & Acquisitions, Expansion Plans

4 OTC Drug and Dietary Supplement Breakdown Data by Type
4.1 Global OTC Drug and Dietary Supplement Historic Market Size by Type (2016-2021)
4.2 Global OTC Drug and Dietary Supplement Forecasted Market Size by Type (2022-2027)

5 OTC Drug and Dietary Supplement Breakdown Data by Application
5.1 Global OTC Drug and Dietary Supplement Historic Market Size by Application (2016-2021)
5.2 Global OTC Drug and Dietary Supplement Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America OTC Drug and Dietary Supplement Market Size (2016-2027)
6.2 North America OTC Drug and Dietary Supplement Market Size by Type
6.2.1 North America OTC Drug and Dietary Supplement Market Size by Type (2016-2021)
6.2.2 North America OTC Drug and Dietary Supplement Market Size by Type (2022-2027)
6.2.3 North America OTC Drug and Dietary Supplement Market Size by Type (2016-2027)
6.3 North America OTC Drug and Dietary Supplement Market Size by Application
6.3.1 North America OTC Drug and Dietary Supplement Market Size by Application (2016-2021)
6.3.2 North America OTC Drug and Dietary Supplement Market Size by Application (2022-2027)
6.3.3 North America OTC Drug and Dietary Supplement Market Size by Application (2016-2027)
6.4 North America OTC Drug and Dietary Supplement Market Size by Country
6.4.1 North America OTC Drug and Dietary Supplement Market Size by Country (2016-2021)
6.4.2 North America OTC Drug and Dietary Supplement Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe OTC Drug and Dietary Supplement Market Size (2016-2027)
7.2 Europe OTC Drug and Dietary Supplement Market Size by Type
7.2.1 Europe OTC Drug and Dietary Supplement Market Size by Type (2016-2021)
7.2.2 Europe OTC Drug and Dietary Supplement Market Size by Type (2022-2027)
7.2.3 Europe OTC Drug and Dietary Supplement Market Size by Type (2016-2027)
7.3 Europe OTC Drug and Dietary Supplement Market Size by Application
7.3.1 Europe OTC Drug and Dietary Supplement Market Size by Application (2016-2021)
7.3.2 Europe OTC Drug and Dietary Supplement Market Size by Application (2022-2027)
7.3.3 Europe OTC Drug and Dietary Supplement Market Size by Application (2016-2027)
7.4 Europe OTC Drug and Dietary Supplement Market Size by Country
7.4.1 Europe OTC Drug and Dietary Supplement Market Size by Country (2016-2021)
7.4.2 Europe OTC Drug and Dietary Supplement Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific OTC Drug and Dietary Supplement Market Size (2016-2027)
8.2 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Type
8.2.1 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Type (2016-2021)
8.2.2 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Type (2022-2027)
8.2.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Type (2016-2027)
8.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Application
8.3.1 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Application (2016-2021)
8.3.2 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Application (2022-2027)
8.3.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Application (2016-2027)
8.4 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region
8.4.1 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2016-2021)
8.4.2 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America OTC Drug and Dietary Supplement Market Size (2016-2027)
9.2 Latin America OTC Drug and Dietary Supplement Market Size by Type
9.2.1 Latin America OTC Drug and Dietary Supplement Market Size by Type (2016-2021)
9.2.2 Latin America OTC Drug and Dietary Supplement Market Size by Type (2022-2027)
9.2.3 Latin America OTC Drug and Dietary Supplement Market Size by Type (2016-2027)
9.3 Latin America OTC Drug and Dietary Supplement Market Size by Application
9.3.1 Latin America OTC Drug and Dietary Supplement Market Size by Application (2016-2021)
9.3.2 Latin America OTC Drug and Dietary Supplement Market Size by Application (2022-2027)
9.3.3 Latin America OTC Drug and Dietary Supplement Market Size by Application (2016-2027)
9.4 Latin America OTC Drug and Dietary Supplement Market Size by Country
9.4.1 Latin America OTC Drug and Dietary Supplement Market Size by Country (2016-2021)
9.4.2 Latin America OTC Drug and Dietary Supplement Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa OTC Drug and Dietary Supplement Market Size (2016-2027)
10.2 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type
10.2.1 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2016-2021)
10.2.2 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2022-2027)
10.2.3 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2016-2027)
10.3 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application
10.3.1 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2016-2021)
10.3.2 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2022-2027)
10.3.3 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2016-2027)
10.4 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country
10.4.1 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2016-2021)
10.4.2 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer OTC Drug and Dietary Supplement Introduction
11.1.4 Pfizer Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Amway
11.2.1 Amway Company Details
11.2.2 Amway Business Overview
11.2.3 Amway OTC Drug and Dietary Supplement Introduction
11.2.4 Amway Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.2.5 Amway Recent Development
11.3 Suntory
11.3.1 Suntory Company Details
11.3.2 Suntory Business Overview
11.3.3 Suntory OTC Drug and Dietary Supplement Introduction
11.3.4 Suntory Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.3.5 Suntory Recent Development
11.4 Glanbia
11.4.1 Glanbia Company Details
11.4.2 Glanbia Business Overview
11.4.3 Glanbia OTC Drug and Dietary Supplement Introduction
11.4.4 Glanbia Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.4.5 Glanbia Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK OTC Drug and Dietary Supplement Introduction
11.5.4 GSK Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.5.5 GSK Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott OTC Drug and Dietary Supplement Introduction
11.6.4 Abbott Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Herbalife
11.7.1 Herbalife Company Details
11.7.2 Herbalife Business Overview
11.7.3 Herbalife OTC Drug and Dietary Supplement Introduction
11.7.4 Herbalife Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.7.5 Herbalife Recent Development
11.8 Reckitt Benckiser
11.8.1 Reckitt Benckiser Company Details
11.8.2 Reckitt Benckiser Business Overview
11.8.3 Reckitt Benckiser OTC Drug and Dietary Supplement Introduction
11.8.4 Reckitt Benckiser Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.8.5 Reckitt Benckiser Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer OTC Drug and Dietary Supplement Introduction
11.9.4 Bayer Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Blackmores
11.10.1 Blackmores Company Details
11.10.2 Blackmores Business Overview
11.10.3 Blackmores OTC Drug and Dietary Supplement Introduction
11.10.4 Blackmores Revenue in OTC Drug and Dietary Supplement Business (2016-2021)
11.10.5 Blackmores Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Powders
Table 4. Key Players of Capsules
Table 5. Key Players of Liquids
Table 6. Global OTC Drug and Dietary Supplement Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global OTC Drug and Dietary Supplement Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global OTC Drug and Dietary Supplement Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global OTC Drug and Dietary Supplement Market Share by Regions (2016-2021)
Table 10. Global OTC Drug and Dietary Supplement Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global OTC Drug and Dietary Supplement Market Share by Regions (2022-2027)
Table 12. OTC Drug and Dietary Supplement Market Trends
Table 13. OTC Drug and Dietary Supplement Market Drivers
Table 14. OTC Drug and Dietary Supplement Market Challenges
Table 15. OTC Drug and Dietary Supplement Market Restraints
Table 16. Global OTC Drug and Dietary Supplement Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global OTC Drug and Dietary Supplement Market Share by Players (2016-2021)
Table 18. Global Top OTC Drug and Dietary Supplement Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug and Dietary Supplement as of 2020)
Table 19. Ranking of Global Top OTC Drug and Dietary Supplement Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by OTC Drug and Dietary Supplement Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players OTC Drug and Dietary Supplement Product Solution and Service
Table 23. Date of Enter into OTC Drug and Dietary Supplement Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global OTC Drug and Dietary Supplement Market Size by Type (2016-2021) (US$ Million)
Table 26. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2016-2021)
Table 27. Global OTC Drug and Dietary Supplement Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global OTC Drug and Dietary Supplement Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2016-2021)
Table 31. Global OTC Drug and Dietary Supplement Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America OTC Drug and Dietary Supplement Market Size by Type (2016-2021) (US$ Million)
Table 34. North America OTC Drug and Dietary Supplement Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America OTC Drug and Dietary Supplement Market Size by Application (2016-2021) (US$ Million)
Table 36. North America OTC Drug and Dietary Supplement Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America OTC Drug and Dietary Supplement Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America OTC Drug and Dietary Supplement Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe OTC Drug and Dietary Supplement Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe OTC Drug and Dietary Supplement Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe OTC Drug and Dietary Supplement Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe OTC Drug and Dietary Supplement Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe OTC Drug and Dietary Supplement Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe OTC Drug and Dietary Supplement Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America OTC Drug and Dietary Supplement Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America OTC Drug and Dietary Supplement Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America OTC Drug and Dietary Supplement Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America OTC Drug and Dietary Supplement Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America OTC Drug and Dietary Supplement Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America OTC Drug and Dietary Supplement Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer OTC Drug and Dietary Supplement Product
Table 66. Pfizer Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Amway Company Details
Table 69. Amway Business Overview
Table 70. Amway OTC Drug and Dietary Supplement Product
Table 71. Amway Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 72. Amway Recent Development
Table 73. Suntory Company Details
Table 74. Suntory Business Overview
Table 75. Suntory OTC Drug and Dietary Supplement Product
Table 76. Suntory Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 77. Suntory Recent Development
Table 78. Glanbia Company Details
Table 79. Glanbia Business Overview
Table 80. Glanbia OTC Drug and Dietary Supplement Product
Table 81. Glanbia Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 82. Glanbia Recent Development
Table 83. GSK Company Details
Table 84. GSK Business Overview
Table 85. GSK OTC Drug and Dietary Supplement Product
Table 86. GSK Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 87. GSK Recent Development
Table 88. Abbott Company Details
Table 89. Abbott Business Overview
Table 90. Abbott OTC Drug and Dietary Supplement Product
Table 91. Abbott Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Herbalife Company Details
Table 94. Herbalife Business Overview
Table 95. Herbalife OTC Drug and Dietary Supplement Product
Table 96. Herbalife Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 97. Herbalife Recent Development
Table 98. Reckitt Benckiser Company Details
Table 99. Reckitt Benckiser Business Overview
Table 100. Reckitt Benckiser Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 101. Reckitt Benckiser Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer OTC Drug and Dietary Supplement Product
Table 105. Bayer Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 106. Bayer Recent Development
Table 107. Blackmores Company Details
Table 108. Blackmores Business Overview
Table 109. Blackmores OTC Drug and Dietary Supplement Product
Table 110. Blackmores Revenue in OTC Drug and Dietary Supplement Business (2016-2021) & (US$ Million)
Table 111. Blackmores Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Drug and Dietary Supplement Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Powders Features
Figure 4. Capsules Features
Figure 5. Liquids Features
Figure 6. Global OTC Drug and Dietary Supplement Market Share by Application: 2020 VS 2027
Figure 7. Convenience Stores Case Studies
Figure 8. Pharmacies Case Studies
Figure 9. Supermarkets Case Studies
Figure 10. OTC Drug and Dietary Supplement Report Years Considered
Figure 11. Global OTC Drug and Dietary Supplement Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global OTC Drug and Dietary Supplement Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global OTC Drug and Dietary Supplement Market Share by Regions: 2020 VS 2027
Figure 14. Global OTC Drug and Dietary Supplement Market Share by Regions (2022-2027)
Figure 15. Global OTC Drug and Dietary Supplement Market Share by Players in 2020
Figure 16. Global Top OTC Drug and Dietary Supplement Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug and Dietary Supplement as of 2020
Figure 17. The Top 10 and 5 Players Market Share by OTC Drug and Dietary Supplement Revenue in 2020
Figure 18. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2016-2021)
Figure 19. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2022-2027)
Figure 20. North America OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America OTC Drug and Dietary Supplement Market Share by Type (2016-2027)
Figure 22. North America OTC Drug and Dietary Supplement Market Share by Application (2016-2027)
Figure 23. North America OTC Drug and Dietary Supplement Market Share by Country (2016-2027)
Figure 24. United States OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe OTC Drug and Dietary Supplement Market Share by Type (2016-2027)
Figure 28. Europe OTC Drug and Dietary Supplement Market Share by Application (2016-2027)
Figure 29. Europe OTC Drug and Dietary Supplement Market Share by Country (2016-2027)
Figure 30. Germany OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific OTC Drug and Dietary Supplement Market Share by Type (2016-2027)
Figure 38. Asia-Pacific OTC Drug and Dietary Supplement Market Share by Application (2016-2027)
Figure 39. Asia-Pacific OTC Drug and Dietary Supplement Market Share by Region (2016-2027)
Figure 40. China OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America OTC Drug and Dietary Supplement Market Share by Type (2016-2027)
Figure 48. Latin America OTC Drug and Dietary Supplement Market Share by Application (2016-2027)
Figure 49. Latin America OTC Drug and Dietary Supplement Market Share by Country (2016-2027)
Figure 50. Mexico OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa OTC Drug and Dietary Supplement Market Share by Type (2016-2027)
Figure 54. Middle East & Africa OTC Drug and Dietary Supplement Market Share by Application (2016-2027)
Figure 55. Middle East & Africa OTC Drug and Dietary Supplement Market Share by Country (2016-2027)
Figure 56. Turkey OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE OTC Drug and Dietary Supplement Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 60. Amway Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 61. Suntory Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 62. Glanbia Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 65. Herbalife Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 66. Reckitt Benckiser Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 68. Blackmores Revenue Growth Rate in OTC Drug and Dietary Supplement Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Global OTC Probiotics Supplement Market Size, Status and Forecast 2021-2027
QFJ1-5922 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、OTCプロバイオティクスサプリメントの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、粉末、シロップ）、用途別市場規模（オンライン、オフライン）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のミネラルサプリメント錠剤市場規模・現状・予測（2021年-2027年）

Global Mineral Supplement Tablets Market Size, Status and Forecast 2021-2027
QFJ1-5862 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ミネラルサプリメント錠剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カルシウム、マグネシウム、鉄、クロム、カリウム、カリウム、亜鉛、セレン、その他）、用途別市場規模（大人用、子供用）、主要地域別市...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の海洋性医薬品市場規模・現状・予測（2021年-2027年）

Global Marine Drug Market Size, Status and Forecast 2021-2027
QFJ1-5842 2021年6月 116Pages
QYResearch社発行の本調査レポートでは、海洋性医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、健康補助食品）、用途別市場規模（病院・クリニック、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年）

Global Hypothyroidism Drug Market Size, Status and Forecast 2021-2027
QFJ1-4342 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、甲状腺機能低下症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）、用途別市場規模（病院、診療所、その他）、主要地域...

世界の抗コリン薬市場規模・現状・予測（2021年-2027年）

Global Anticholinergic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5583 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗コリン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口、局所）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のOTCプロバイオティクスサプリメント市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global OTC Probiotics Supplement Market The global OTC Probiotics Supplement market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
ペット用栄養補助食品のグローバル市場調査 2019年 The global Pet Dietary Supplement market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pet Dietary Supplement volume and value at global level, regional level and company level. From a global perspective…
世界のミネラルサプリメント錠剤市場規模・現状・予測（2021年-2027年） Rising prevalence of diseases such as osteoporosis, anemia, cancer, and diabetes is boosting the market growth, as these supplements are commonly used in managing such conditions. Market Analysis and Insights: Global Mineral Supplement Tablets Market The global Mineral Supplement Tablets market size…
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年） Palbociclib is a drug manufactured by Pfizer, marketed under the brand Ibrance, and it is used for the treatment of hormone receptor-positive (HR+ve) and human epidermal growth factor receptor 2-negative (HER2-), advanced or metastatic breast cancer. It inhibits the activity of cyclin dependent kina…